Cbn cannabinoid
Pro Research Analysisby 
Searched over 200M research papers for "cbn cannabinoid"
Cannabinol (CBN) and Its Effects: A Comprehensive Overview
Introduction to Cannabinol (CBN)
Cannabinol (CBN) is a minor cannabinoid derived from the oxidation of delta-9-tetrahydrocannabinol (THC), a primary psychoactive component of Cannabis sativa. Unlike THC, CBN is known for its minimal central nervous system (CNS) activity, making it a subject of interest for its potential therapeutic benefits without significant psychoactive effects3 6.
CBN and Sleep Disorders
Potential Therapeutic Effects on Insomnia
Insomnia is a prevalent sleep disorder with limited effective pharmacotherapies. Recent studies have explored the potential of CBN as a treatment for insomnia. A randomized, double-blind, placebo-controlled, cross-over study investigated the effects of CBN on sleep and next-day function in individuals with insomnia disorder. Participants received either 30 mg or 300 mg of CBN or a placebo, with outcomes measured through polysomnography and neurobehavioral tests. The primary outcome focused on wake after sleep onset minutes, while secondary outcomes included changes in sleep architecture and subjective sleep quality1 2 4.
Study Findings
The studies indicated that CBN might improve sleep continuity and quality, although the results are preliminary and require further validation through larger clinical trials. The research highlighted the need for novel interventions in insomnia and suggested that CBN could be a promising candidate1 2 4.
CBN and Immune Modulation
Mechanisms of Immune Suppression
CBN has been shown to modulate immune responses through its interaction with cannabinoid receptors, particularly CB2. It inhibits the cyclic AMP (cAMP) signaling cascade, leading to reduced protein kinase A activity and decreased transcription factor binding to cAMP response elements and kappaB motifs. This results in the suppression of lymphoproliferative responses and interleukin-2 (IL-2) secretion in immune cells3 7.
Implications for Immune Function
The immunosuppressive properties of CBN suggest its potential use in conditions where immune modulation is beneficial. However, the exact clinical applications and safety profiles need further exploration3 7.
CBN and Developmental Effects
Impact on Embryonic Development
Studies on zebrafish embryos have shown that CBN exposure during critical developmental stages can lead to dose-dependent malformations, increased mortality, and altered neuronal development. These effects are primarily mediated through CB2 receptors, as blocking these receptors mitigated many of the observed defects9 10.
Behavioral and Physiological Changes
CBN exposure in zebrafish larvae resulted in significant behavioral changes, including altered locomotion and response to stimuli. Additionally, CBN affected heart morphology and function, indicating potential risks associated with its use during development9 10.
Chemical Stability and Degradation
Kinetics of CBN Formation
The formation of CBN from THC is influenced by temperature and pH conditions. Higher temperatures and acidic environments accelerate the degradation of THC and the formation of CBN. Understanding these kinetics is crucial for optimizing storage conditions and manufacturing processes for cannabis products8.
Conclusion
Cannabinol (CBN) is emerging as a cannabinoid of interest due to its potential therapeutic benefits, particularly in sleep disorders and immune modulation. Preliminary studies suggest that CBN may improve sleep quality and continuity in individuals with insomnia and modulate immune responses through CB2 receptor interactions. However, its developmental effects and chemical stability highlight the need for careful consideration in its application and further research to fully understand its safety and efficacy.
Sources and full results
Most relevant research papers on this topic
Cannabinol (CBN; 30 and 300 mg) effects on sleep and next-day function in insomnia disorder (‘CUPID’ study): protocol for a randomised, double-blind, placebo-controlled, cross-over, three-arm, proof-of-concept trial
Cannabinol (CBN) may be an effective and safe treatment for insomnia disorder, as demonstrated in a randomized, double-blind, placebo-controlled study.
RCT0346 Cannabinol (CBN) effects in insomnia disorder: A randomised, double-blind, placebo-controlled, crossover, clinical trial protocol
Cannabinol (CBN) at 30 and 300 mg doses may improve sleep continuity and next-day function in adults with insomnia disorder.
RCTInhibition of the cyclic AMP signaling cascade and nuclear factor binding to CRE and kappaB elements by cannabinol, a minimally CNS-active cannabinoid.
Cannabinol, a minimally CNS-active cannabinoid, inhibits immune function and cAMP signaling in mouse lymphoid cells, supporting the involvement of CB2 receptors in immune modulation by cannabimimetic agents.
In Vitro Study
Highly CitedP066 A randomised, double-blind, placebo-controlled, single-dose, crossover, pilot study investigating the effects of cannabinol (CBN) 30 mg and 300 mg on sleep architecture and next-day function in insomnia disorder
Cannabinol (CBN) 30 and 300 mg may improve sleep continuity and next-day function in adults with insomnia disorder, potentially benefiting larger clinical trials.
RCTCannabinoid-Mediated Elevation of Intracellular Calcium: A Structure-Activity Relationship
Classic tricyclic cannabinoids with structural similarity to 9-THC elicit a robust influx of calcium in T cells, potentially through receptor-operated cation channels.
In Vitro StudyCannabinol: History, Syntheses, and Biological Profile of the Greatest “Minor” Cannabinoid
Cannabinol (CBN, 5a) is a significant "minor" cannabinoid with promising pharmacological potential and significant impact on the development of new synthetic methodologies.
Rigorous JournalCannabinol-Mediated Inhibition of Nuclear Factor-k B , cAMP Response Element-Binding Protein , and Interleukin-2 Secretion by Activated Thymocytes 1
Cannabinol inhibits thymocyte function and IL-2 production by inhibiting CREB/ATF and NF-kappaB/Rel transcription factors in activated thymocytes.
Kinetics of CBD, Δ9-THC Degradation and Cannabinol Formation in Cannabis Resin at Various Temperature and pH Conditions.
The major cannabinoids (CBD, CBN, and 9-THC) react more quickly at high temperature and in acidic solutions, with the minimum transformation achieved at low temperature, slightly to moderately acidic pH values, and short-time processing.
Cannabinoid receptor 2 (Cb2r) mediates cannabinol (CBN) induced developmental defects in zebrafish
CBN exposure during gastrulation in zebrafish leads to developmental defects and reduced locomotion, primarily through CB2R-mediated mechanisms.
Non-RCT
Animal StudyRigorous JournalCannabinol in the spotlight: Toxicometabolomic study and behavioral analysis of zebrafish embryos exposed to the unknown cannabinoid.
Cannabinol exposure increases toxic effects on zebrafish larvae, causing malformations and behavioral changes, with a dose-dependent LD50 value.
Non-RCTAnimal Study